Literature DB >> 23944680

Protein kinase D isoforms: new targets for therapy in invasive breast cancers?

Sahra Borges, Peter Storz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23944680      PMCID： PMC3856925          DOI： 10.1586/14737140.2013.816460

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN： 1473-7140            Impact factor:   4.512


× No keyword cloud information.
  29 in total

1.  Neuregulin mediates F-actin-driven cell migration through inhibition of protein kinase D1 via Rac1 protein.

Authors:  Heike Döppler; Ligia I Bastea; Tim Eiseler; Peter Storz
Journal:  J Biol Chem       Date:  2012-11-12       Impact factor: 5.157

2.  Protein kinase D1 suppresses epithelial-to-mesenchymal transition through phosphorylation of snail.

Authors:  Cheng Du; Chuanyou Zhang; Sazzad Hassan; Md Helal Uddin Biswas; K C Balaji
Journal:  Cancer Res       Date:  2010-10-12       Impact factor: 12.701

3.  E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer.

Authors:  Meena Jaggi; Prema S Rao; David J Smith; Margaret J Wheelock; Keith R Johnson; George P Hemstreet; K C Balaji
Journal:  Cancer Res       Date:  2005-01-15       Impact factor: 12.701

4.  Novel protein kinase D inhibitors cause potent arrest in prostate cancer cell growth and motility.

Authors:  Courtney R Lavalle; Karla Bravo-Altamirano; Karthik V Giridhar; Jun Chen; Elizabeth Sharlow; John S Lazo; Peter Wipf; Q Jane Wang
Journal:  BMC Chem Biol       Date:  2010-05-05

5.  Characterization of the biological effects of a novel protein kinase D inhibitor in endothelial cells.

Authors:  Ian M Evans; Azadeh Bagherzadeh; Mark Charles; Tony Raynham; Chris Ireson; Alexandra Boakes; Lloyd Kelland; Ian C Zachary
Journal:  Biochem J       Date:  2010-08-01       Impact factor: 3.857

6.  Co-expression of neuregulins 1, 2, 3 and 4 in human breast cancer.

Authors:  Mariana Dunn; Prakash Sinha; Rebecca Campbell; Edith Blackburn; Neil Levinson; Raj Rampaul; Tom Bates; Stephen Humphreys; William J Gullick
Journal:  J Pathol       Date:  2004-06       Impact factor: 7.996

7.  Protein kinases D2 and D3 are novel growth regulators in HCC1806 triple-negative breast cancer cells.

Authors:  Qin Hao; Raymond McKenzie; Huachen Gan; Hua Tang
Journal:  Anticancer Res       Date:  2013-02       Impact factor: 2.480

8.  PKD2 and PKD3 promote prostate cancer cell invasion by modulating NF-κB- and HDAC1-mediated expression and activation of uPA.

Authors:  Zhipeng Zou; Fangyin Zeng; Wanfu Xu; Chunxia Wang; Zhiyong Ke; Q Jane Wang; Fan Deng
Journal:  J Cell Sci       Date:  2012-07-13       Impact factor: 5.285

9.  Curcumin attenuates β-catenin signaling in prostate cancer cells through activation of protein kinase D1.

Authors:  Vasudha Sundram; Subhash C Chauhan; Mara Ebeling; Meena Jaggi
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

10.  Protein kinase D1 regulates cofilin-mediated F-actin reorganization and cell motility through slingshot.

Authors:  Tim Eiseler; Heike Döppler; Irene K Yan; Kanae Kitatani; Kensaku Mizuno; Peter Storz
Journal:  Nat Cell Biol       Date:  2009-03-29       Impact factor: 28.824
View more
  9 in total

1.  Protein kinase D2 silencing reduced motility of doxorubicin-resistant MCF7 cells.

Authors:  Aktan Alpsoy; Ufuk Gündüz
Journal:  Tumour Biol       Date:  2015-01-21

2.  Protein kinase d as a potential chemotherapeutic target for colorectal cancer.

Authors:  Ning Wei; Edward Chu; Peter Wipf; John C Schmitz
Journal:  Mol Cancer Ther       Date:  2014-03-14       Impact factor: 6.261

3.  Effective Targeting of Estrogen Receptor-Negative Breast Cancers with the Protein Kinase D Inhibitor CRT0066101.

Authors:  Sahra Borges; Edith A Perez; E Aubrey Thompson; Derek C Radisky; Xochiquetzal J Geiger; Peter Storz
Journal:  Mol Cancer Ther       Date:  2015-04-07       Impact factor: 6.261

4.  Opposing growth regulatory roles of protein kinase D isoforms in human keratinocytes.

Authors:  Vladislav Ryvkin; Mohammad Rashel; Trivikram Gaddapara; Soosan Ghazizadeh
Journal:  J Biol Chem       Date:  2015-03-23       Impact factor: 5.157

Review 5.  Protein kinase D signaling in cancer: A friend or foe?

Authors:  Adhiraj Roy; Jing Ye; Fan Deng; Qiming Jane Wang
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-05-31       Impact factor: 10.680

6.  An integrated bioinformatics analysis to dissect kinase dependency in triple negative breast cancer.

Authors:  Karen A Ryall; Jihye Kim; Peter J Klauck; Jimin Shin; Minjae Yoo; Anastasia Ionkina; Todd M Pitts; John J Tentler; Jennifer R Diamond; S Gail Eckhardt; Lynn E Heasley; Jaewoo Kang; Aik Choon Tan
Journal:  BMC Genomics       Date:  2015-12-09       Impact factor: 3.969

7.  Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma.

Authors:  Liyong Zhang; Zhihong Li; Yehai Liu; Shuping Xu; Manuj Tandon; Brittany Appelboom; Courtney R LaValle; Simion I Chiosea; Lin Wang; Malabika Sen; Vivian W Y Lui; Jennifer R Grandis; Q Jane Wang
Journal:  BMC Cancer       Date:  2018-11-12       Impact factor: 4.430

Review 8.  Protein Kinase D Enzymes as Regulators of EMT and Cancer Cell Invasion.

Authors:  Nisha Durand; Sahra Borges; Peter Storz
Journal:  J Clin Med       Date:  2016-02-03       Impact factor: 4.241

9.  Protein Kinase D3 promotes the cell proliferation by activating the ERK1/c-MYC axis in breast cancer.

Authors:  Yan Liu; Hang Song; Shiyi Yu; Kuo-Hsiang Huang; Xinxing Ma; Yehui Zhou; Shuang Yu; Jingzhong Zhang; Liming Chen
Journal:  J Cell Mol Med       Date:  2020-01-16       Impact factor: 5.310
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.